Literature DB >> 2157045

Complete nucleotide sequence of infectious Coxsackievirus B3 cDNA: two initial 5' uridine residues are regained during plus-strand RNA synthesis.

W M Klump1, I Bergmann, B C Müller, D Ameis, R Kandolf.   

Abstract

A full-length reverse-transcribed, infectious cDNA copy of coxsackievirus B3 (CVB3) was used to determine the nucleotide sequence of this cardiotropic enterovirus. Comparison of the nucleotide sequence and the deduced amino acid sequence of the viral precursor polyprotein with the sequences of other group B coxsackieviruses (CVB1 and CVB4) demonstrates a high degree of genetic identity. They share about 80% homology at the nucleotide level and about 90% when the amino acid sequences of the polyproteins are compared. The potential processing sites of the coxsackievirus polyproteins, as deduced from alignment with the poliovirus sequence, are conserved among these enteroviruses with the exception of the cleavage sites between VP1 and 2Apro and between polypeptides 2B and 2C. Comparison of the 5' termini of the enteroviral genomes reveals a high degree of identity, including the initial 5' consensus UUAAAACAGC, suggesting essential functions in virus replication. An important finding concerning the molecular basis of infectivity was that both recombinant CVB3 cDNA and in vitro-synthesized CVB3 RNA transcripts are infectious, although two initial 5' uridine residues found on the authentic CVB3 RNA were missing. Here, we report that cDNA-generated CVB3, as well as CVB3 generated by in vitro-synthesized RNA transcripts, regains the authentic initial 5' uridine residues during replication in transfected cells, indicating that the picornaviral primer molecule VPg-pUpU may be uridylylated in a template-independent fashion. The generation of virus or virus mutants with infectious recombinant CVB3 cDNA and in vitro-synthesized infectious CVB3 transcripts should provide a valuable means for studying the molecular basis of the pathogenicity of this cardiotropic enterovirus.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2157045      PMCID: PMC249292          DOI: 10.1128/JVI.64.4.1573-1583.1990

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Infectious ribonucleic acid derived from enteroviruses.

Authors:  K SPRUNT; W M REDMAN; H E ALEXANDER
Journal:  Proc Soc Exp Biol Med       Date:  1959 Aug-Sep

2.  Antigenic structure of polioviruses of serotypes 1, 2 and 3.

Authors:  P D Minor; M Ferguson; D M Evans; J W Almond; J P Icenogle
Journal:  J Gen Virol       Date:  1986-07       Impact factor: 3.891

3.  The complete nucleotide sequence of coxsackievirus B4 and its comparison to other members of the Picornaviridae.

Authors:  O Jenkins; J D Booth; P D Minor; J W Almond
Journal:  J Gen Virol       Date:  1987-07       Impact factor: 3.891

4.  Genome of coxsackievirus B3.

Authors:  A M Lindberg; P O Stålhandske; U Pettersson
Journal:  Virology       Date:  1987-01       Impact factor: 3.616

5.  The atomic structure of Mengo virus at 3.0 A resolution.

Authors:  M Luo; G Vriend; G Kamer; I Minor; E Arnold; M G Rossmann; U Boege; D G Scraba; G M Duke; A C Palmenberg
Journal:  Science       Date:  1987-01-09       Impact factor: 47.728

6.  Complete nucleotide sequence of the genome of coxsackievirus B1.

Authors:  N Iizuka; S Kuge; A Nomoto
Journal:  Virology       Date:  1987-01       Impact factor: 3.616

7.  In situ detection of enteroviral genomes in myocardial cells by nucleic acid hybridization: an approach to the diagnosis of viral heart disease.

Authors:  R Kandolf; D Ameis; P Kirschner; A Canu; P H Hofschneider
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

8.  Membrane-dependent uridylylation of the genome-linked protein VPg of poliovirus.

Authors:  T Takegami; R J Kuhn; C W Anderson; E Wimmer
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

9.  Analysis of RNA synthesis of type 1 poliovirus by using an in vitro molecular genetic approach.

Authors:  H Toyoda; C F Yang; N Takeda; A Nomoto; E Wimmer
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

10.  Hepatitis A virus cDNA and its RNA transcripts are infectious in cell culture.

Authors:  J I Cohen; J R Ticehurst; S M Feinstone; B Rosenblum; R H Purcell
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

View more
  92 in total

1.  Poliovirus requires a precise 5' end for efficient positive-strand RNA synthesis.

Authors:  J Herold; R Andino
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

2.  Mapping the genetic determinants of pathogenicity and plaque phenotype in swine vesicular disease virus.

Authors:  T Kanno; D Mackay; T Inoue; G Wilsden; M Yamakawa; R Yamazoe; S Yamaguchi; J Shirai; P Kitching; Y Murakami
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

3.  Cross-talk between orientation-dependent recognition determinants of a complex control RNA element, the enterovirus oriR.

Authors:  W J Melchers; J M Bakkers; H J Bruins Slot; J M Galama; V I Agol; E V Pilipenko
Journal:  RNA       Date:  2000-07       Impact factor: 4.942

Review 4.  Non-template functions of viral RNA in picornavirus replication.

Authors:  Sushma A Ogram; James B Flanegan
Journal:  Curr Opin Virol       Date:  2011-11       Impact factor: 7.090

5.  Progress in targeted delivery of siRNA to combat Coxsackievirus.

Authors:  Anju Gautam
Journal:  Protein Cell       Date:  2011-11       Impact factor: 14.870

6.  Human astrocytic cells support persistent coxsackievirus B3 infection.

Authors:  Xiaowei Zhang; Zhenhua Zheng; Bo Shu; Xijuan Liu; Zhenfeng Zhang; Yan Liu; Bingke Bai; Qinxue Hu; Panyong Mao; Hanzhong Wang
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

7.  3'-Terminal sequence in poliovirus negative-strand templates is the primary cis-acting element required for VPgpUpU-primed positive-strand initiation.

Authors:  Nidhi Sharma; Brian J O'Donnell; James B Flanegan
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

8.  Evolutionary constraints on chaperone-mediated folding provide an antiviral approach refractory to development of drug resistance.

Authors:  Ron Geller; Marco Vignuzzi; Raul Andino; Judith Frydman
Journal:  Genes Dev       Date:  2007-01-15       Impact factor: 11.361

9.  Recombination in circulating enteroviruses.

Authors:  Alexander N Lukashev; Vasilii A Lashkevich; Olga E Ivanova; Galina A Koroleva; Ari E Hinkkanen; Jorma Ilonen
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

10.  Structure of the 5' nontranslated region of the coxsackievirus b3 genome: Chemical modification and comparative sequence analysis.

Authors:  Jennifer M Bailey; William E Tapprich
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.